| Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine. | |
| | |
MedLine Citation:
|
PMID: 16887217 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 48-year-old woman presented with acute coronary syndrome and underwent coronary angiography which revealed myocardial bridging at the distal end of the left anterior descending artery with otherwise normal coronary arteries. The patient used to take ergotamine for her chronic migraine. Possible association with myocardial bridging which was found in this patient is discussed. |
| | |
Authors:
|
Avi Shimony; Ayal Romem; Sharon Horowitz; Raphael Boehm; Jacob Horowitz |
Related Documents
:
|
7967047 - Clinical and angiographic characteristics of patients with multivessel coronary spasm i... 2513117 - The incidence of myocardial bridges in heart transplants. 3946167 - Effect of programmed ventricular stimulation on myocardial lactate extraction in patien... 9550177 - Ultrasonic tissue characterization for coronary care unit patients with acute myocardia... 12189287 - Circulatory assist devices 2000: an update. 20354047 - Malignant middle cerebral artery (mca) infarction: pathophysiology, diagnosis and manag... |
Publication Detail:
|
Type: Case Reports; Letter Date: 2006-08-02 |
Journal Detail:
|
Title: International journal of cardiology Volume: 113 ISSN: 1874-1754 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2006 Oct |
Date Detail:
|
Created Date: 2006-11-06 Completed Date: 2007-01-04 Revised Date: 2010-05-10 |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: E7-8 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Coronary Disease / chemically induced* Coronary Vessel Anomalies / complications* Ergotamine / adverse effects*, therapeutic use Female Humans Middle Aged Migraine Disorders / complications*, drug therapy* Syndrome Vasoconstrictor Agents / adverse effects*, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Vasoconstrictor Agents; 113-15-5/Ergotamine |
| Comments/Corrections | |
Comment In:
|
Int J Cardiol. 2010 May 14;141(1):111-4
[PMID:
19135734
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinica...
Next Document: Intracoronary air embolism in open heart surgery--an uncommon source of myocardial ischaemia.